Home › Targets › HLA-A*02:01

HLA-A*02:01 (1 companies · 8 programs)

Companies with an active program directed at HLA-A*02:01.

Immunocore Holdings plc IMCR

KIMMTRAK — Uveal Melanoma Approved
brenetafusp — Cutaneous Melanoma Phase 3
brenetafusp — Ovarian Cancer Phase 1
brenetafusp — Non-Small Cell Lung Cancer Phase 1
IMC-P115C Phase 1
IMC-R117C — Colorectal Cancer Phase 1
IMC-S118AI — Type 1 Diabetes Preclinical
KIMMTRAK — Cutaneous Melanoma Phase 3